The effect of sildenafil on ocular blood flow
- 1Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA
- 2Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN, USA
- 3UPMC Eye Center, Eye and Ear Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
- 4Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA, USA
- 5Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA
- 6Midwest Eye Institute, Indianapolis, IN, USA
- 7Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA
- A Harris, Department of Ophthalmology, Indiana University School of Medicine, 702 Rotary Circle, Indianapolis, IN 46202, USA; alharris{at}indiana.edu
- Accepted 4 December 2007
Abstract
Sildenafil is a potent phosphodiesterase (PDE) 5 inhibitor that is used for patients with erectile dysfunction. Sildenafil induces vasodilation in selected smooth muscle via increased levels of guanosine 3′, 5′ cyclic monophosphate and increase in nitric oxide. The vasodilatory effects of the PDE 5 inhibitors led us to review its effect on the ocular vasculature. Sildenafil appears to increase blood flow velocity significantly in the retrobulbar and choroidal circulation. Most studies suggest an increase in choroidal blood flow, with a lesser effect on the retinal vasculature.
Footnotes
-
Funding: Supported in part by an unrestricted grant from Research to Prevent Blindness, Inc.
-
Competing interests: Five of the authors have no proprietary interest in any products or concepts mentioned in this article. AH is a consultant to Pfizer Inc.







